Emergency use authorization for COVID-19 vaccine to depend on clinical trial data: Health Minister
“In a huge country like India, it is critical to prioritise vaccine delivery based on various factors such as risk of exposure, comorbidity among various population groups, the mortality rate among COVID-19 cases, and several others,” the minister said.
No hay comentarios:
Publicar un comentario